Tool Box for Policy Coherence in Access to Medicines and Local Pharmaceutical Production
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Ausgabe
-
Bericht
- Sprache
-
Englisch
- Anmerkungen
-
Lizenzpflichtig
- Klassifikation
-
Wirtschaft
- Ereignis
-
Veröffentlichung
- (wo)
-
Bonn
- (wer)
-
GIZ
- (wann)
-
2017
- Urheber
-
Spennemann, Christoph
- Beteiligte Personen und Organisationen
-
Heineke, Corinna
United Nations Conference on Trade and Development (UNCTAD)
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ). Bonn/Eschborn
- URN
-
urn:nbn:de:101:1-201712231045
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spennemann, Christoph
- Heineke, Corinna
- United Nations Conference on Trade and Development (UNCTAD)
- Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ). Bonn/Eschborn
- GIZ
Entstanden
- 2017
Ähnliche Objekte (12)
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation